| Conservative management of Achilles tendon wounds: results of a retrospective study. Y Kleinman, A Cahn Ostomy/wound Management 57 (4), 32-40, 2011 | 9 | 2011 |
| 1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58 YU MI KANG, GEM MELLONI, A CAHN, I RAZ, F MOURA, DL BHATT, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58 YU MI KANG, GEM MELLONI, A CAHN, I RAZ, F MOURA, DL BHATT, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 192 Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: insights from DECLARE-TIMI 58 TA Zelniker, I Raz, O Mosenzon, JP Dwyer, HJL Heerspink, A Cahn, K Im, ... European Heart Journal 40 (Supplement_1), ehz747. 0052, 2019 | 1 | 2019 |
| 236-OR: Effects of Dapagliflozin on Progression of Diabetic Kidney Disease: Analysis from DECLARE-TIMI 58 Trial O Mosenzon, SD Wiviott, TA Zelniker, HL Heerspink, JP Dwyer, A Cahn, ... Diabetes 68 (Supplement_1), 2019 | 1 | 2019 |
| 244-OR: effects of dapagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes: a predefined analysis from the DECLARE-TIMI 58 randomised, placebo … I Raz, SD Wiviott, I Yanuv, A Rozenberg, TA Zelniker, A Cahn, ... Diabetes 68 (Supplement_1), 2019 | 13 | 2019 |
| 303-OR: effect of dapagliflozin on risk for fast decline in EGFR: analyses from the DECLARE-TIMI 58 trial I Raz, SD Wiviott, HL Heerspink, JP Dwyer, A Cahn, EL Goodrich, ... Diabetes 69 (Supplement_1), 2020 | 3 | 2020 |
| 788-P: The Cardiovascular and Renal Benefits of Dapagliflozin Are Independent of Baseline HbA1c: Analyses from DECLARE-TIMI 58 A Cahn, SD Wiviott, O Mosenzon, S Murphy, EL Goodrich, DL Bhatt, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| A biomarker-based score for risk of hospitalization for heart failure in patients with diabetes DD Berg, SD Wiviott, BM Scirica, TA Zelniker, EL Goodrich, P Jarolim, ... Diabetes Care 44 (11), 2573-2581, 2021 | 23 | 2021 |
| A novel approach to the treatment of diabetic foot abscesses—a case series A Cahn Journal of Wound Care 23 (8), 394-399, 2014 | 19 | 2014 |
| a targeted proteomic approach to identify circulating biomarkers of heart failure risk in patients with type 2 diabetes mellitus in DECLARE-TIMI 58 D Berg, SD Wiviott, I Raz, F Kamanu, KA Im, A Cahn, ofri Mosenzon, ... Circulation 142 (Suppl_3), A16139-A16139, 2020 | 1 | 2020 |
| Acute diabetic foot in post kidney transplantation patients receiving chronic immunosuppression—clinical presentation and outcomes K Gorin, A Cahn, M Leibovitch, S Peled, O Perzon, K Tzukert, A Haze, ... Diabetes/Metabolism Research and Reviews 38 (8), e3575, 2022 | | 2022 |
| Acute renal outcomes with sodium‐glucose co‐transporter‐2 inhibitors: real‐world data analysis A Cahn, C Melzer‐Cohen, R Pollack, G Chodick, V Shalev Diabetes, Obesity and Metabolism 21 (2), 340-348, 2019 | 92 | 2019 |
| Albumin creatinine ratio and cardiovascular outcomes in the SAVOR-TIMI 53 trial O Mosenzon, A Cahn, B Hirshberg, M Sjostrand, RC Ma, G Jermendy, ... DIABETOLOGIA 58, S85-S86, 2015 | 1 | 2015 |
| Alpelisib in Intractable Non–Islet-Cell Tumor Hypoglycemia A Cahn, H Shoyhet-Smoilovsky, M Fischer, A Zick, Y Riahi, S Levenberg, ... New England Journal of Medicine 388 (20), 1911-1913, 2023 | 2 | 2023 |
| An update on DPP-4 inhibitors in the management of type 2 diabetes A Cahn, S Cernea, I Raz Expert opinion on emerging drugs 21 (4), 409-419, 2016 | 73 | 2016 |
| Angiogenic potential of mesenchymal stem cells derived from patients with diabetes seeded on decellularized micro fragments A Assis, YN Gellman, A Cahn, A Haze, S Camargo, E Mitrani Journal of Diabetes and its Complications 35 (10), 108001, 2021 | 2 | 2021 |
| Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58 A Cahn, SD Wiviott, O Mosenzon, EL Goodrich, SA Murphy, I Yanuv, ... Diabetes Care 45 (4), 938-946, 2022 | 24 | 2022 |
| Association of cardiac biomarkers with major adverse cardiovascular events in high-risk patients with diabetes: a secondary analysis of the DECLARE-TIMI 58 trial TA Zelniker, SD Wiviott, O Mosenzon, EL Goodrich, P Jarolim, A Cahn, ... JAMA cardiology 8 (5), 503-509, 2023 | 7 | 2023 |
| Association of inpatient glucose measurements with amputations in patients hospitalized with acute diabetic foot S Peled, R Pollack, O Elishoov, A Haze, A Cahn The Journal of Clinical Endocrinology & Metabolism 104 (11), 5445-5452, 2019 | 26 | 2019 |
Del Prato StefanoUniversity of Pisa在 med.unipi.it 的电子邮件经过验证
Del Prato StefanoUniversity of Pisa在 med.unipi.it 的电子邮件经过验证
Eran LeitersdorfProfessor of Medicine Hebrew University Hadassah Medical School在 hadassah.org.il 的电子邮件经过验证